As of 2025-05-19, the Intrinsic Value of Inogen Inc (INGN) is 0.76 USD. This INGN valuation is based on the model Discounted Cash Flows (Growth Exit 10Y). With the current market price of 6.09 USD, the upside of Inogen Inc is -87.60%.
The range of the Intrinsic Value is 0.63 - 1.94 USD
Based on its market price of 6.09 USD and our intrinsic valuation, Inogen Inc (INGN) is overvalued by 87.60%.
Range | Selected | Upside | |
a | |||
DCF (Growth 5y) | (47.64) - (5.85) | (11.33) | -286.0% |
DCF (Growth 10y) | 0.63 - 1.94 | 0.76 | -87.6% |
DCF (EBITDA 5y) | 5.30 - 6.97 | 6.38 | 4.8% |
DCF (EBITDA 10y) | 8.82 - 13.04 | 11.30 | 85.6% |
Fair Value | -6.67 - -6.67 | -6.67 | -209.57% |
P/E | (22.64) - (44.04) | (34.67) | -669.2% |
EV/EBITDA | (4.24) - (6.34) | (6.60) | -208.3% |
EPV | (15.10) - (22.17) | (18.63) | -406.0% |
DDM - Stable | (11.87) - (79.58) | (45.73) | -850.8% |
DDM - Multi | (0.99) - (5.28) | (1.67) | -127.5% |
Market Cap (mil) | 163.76 |
Beta | 1.21 |
Outstanding shares (mil) | 26.89 |
Enterprise Value (mil) | 49.97 |
Market risk premium | 4.60% |
Cost of Equity | 8.69% |
Cost of Debt | 5.00% |
WACC | 6.77% |